Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause rashes and worsen existing skin conditions, and behaviors like frequent hand-washing can lead to hand dermatitis.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

The document provides detailed care instructions for elderly patients.

Skin problems after waxing led to a sarcoidosis diagnosis.

The convention discussed various skin conditions, treatments, and the importance of continuous learning in dermatology nursing.

Alopecia totalis/universalis is a severe form of hair loss where all body hair is lost.

A man had hiccups for several days after a hair transplant, likely due to medication or nerve irritation, but they stopped on their own.

The patient improved after antiviral treatment for a viral infection.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Follicular mucinosis can be an early sign of aggressive mycosis fungoides.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Scalp itching is common and hard to diagnose due to the complex nerve structure of the scalp.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Erosive pustular dermatosis is a rare skin disease that's hard to treat and affects the scalp or legs.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Clausena anisata may be effective in treating acne due to its ability to fight bacteria, reduce inflammation, and possibly lower sebum production.